呼吸供氧设备市场 - 全球产业规模、份额、趋势、机会和预测，按产品、最终用途、地区和竞争细分，2019-2029F

2023 年，全球呼吸供氧设备市场估值为123.8 亿美元，预计在预测期内将出现令人印象深刻的成长，到2029 年复合年增长率为7.71%。呼吸系统疾病的发生率不断上升疾病（慢性阻塞性肺病）、气喘和睡眠呼吸中止症对有效的氧气输送解决方案产生持续的需求，因此发挥关键作用。此外，鑑于老年人更容易患呼吸系统疾病，全球老年人口的不断增长进一步增加了对呼吸支持的需求。此外，以便携式和用户友好型供氧设备的开发为代表的技术进步成为市场扩张的催化剂，使患者能够在管理健康状况的同时保持积极的生活方式。

主要市场驱动因素

呼吸系统疾病的发生率上升

全球人口老化

医疗保健支出增加

意识和教育

主要市场挑战

定价压力

全球供应链中断

可及性和医疗保健差异

主要市场趋势

便携式和可穿戴设备

智慧型互联设备

家庭医疗保健扩张

细分市场洞察

产品洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球呼吸供氧设备市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 副产品（氧气面罩、鼻插管、文丘里面罩、非循环呼吸面罩、袋阀面罩、CPAP 面罩等）
  • 依最终用途（医院、门诊设施、家庭护理、其他）
  • 按地区
  • 按公司划分 (2023)
• 产品市场地图
  • 按产品分类
  • 按最终用途
  • 按地区

第 6 章：北美呼吸供氧设备市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按产品分类
  • 按最终用途
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲呼吸供氧设备市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按产品分类
  • 按最终用途
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙

第 8 章：亚太地区呼吸供氧设备市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按产品分类
  • 按最终用途
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国

第 9 章：南美洲呼吸供氧设备市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按产品分类
  • 按最终用途
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲呼吸供氧设备市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按产品分类
  • 按最终用途
  • 按国家/地区
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 科威特

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势发展

• 近期发展
• 併购
• 产品发布

第 13 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第14章：竞争格局

• GE Healthcare Technologies Inc
• Koninklijke Philips NV
• ICU Medical Group Ltd (Smiths Medical Group Ltd)
• Invacare Corp
• Medtronic PLC
• Fisher Paykel Healthcare Limited
• ResMed Inc
• CAIRE Inc
• Linde Plc
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd

第 15 章：策略建议

第 16 章：关于我们免责声明

Global Respiratory Oxygen Delivery Devices Market was valued at USD 12.38 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.71% through 2029. In the realm of business, the rising incidence of respiratory ailments like chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea plays a pivotal role by generating a constant requirement for effective oxygen delivery solutions. Additionally, the growing elderly demographic worldwide further amplifies the demand for respiratory support, given that older individuals are more vulnerable to respiratory disorders. Furthermore, the evolution of technology, exemplified by the development of portable and user-friendly oxygen delivery gadgets, serves as a catalyst for market expansion, empowering patients to maintain active lifestyles while managing their health conditions.

Key Market Drivers

Rising Incidence of Respiratory Disorders

Respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and various other conditions, have seen a steady increase in their prevalence worldwide. This concerning trend is not only a public health challenge but also a significant driver behind the growth of the global respiratory oxygen delivery devices market.

The global burden of respiratory disorders is mounting, and the numbers are staggering. COPD, for example, is estimated to affect over 251 million people worldwide, according to the World Health Organization. This surge in the number of people suffering from respiratory diseases has created a substantial and growing market for respiratory oxygen delivery devices.

With the rise in the incidence of respiratory disorders, there is a parallel increase in the demand for oxygen therapy. Many respiratory conditions necessitate the administration of oxygen to manage symptoms and improve patient outcomes. As a result, the need for efficient, accessible, and user-friendly oxygen delivery devices is greater than ever before.

The increasing incidence of respiratory disorders has prompted significant advancements in the field of respiratory care. Healthcare professionals, researchers, and medical device manufacturers are continuously innovating to develop more effective and convenient solutions for patients. These innovations have led to the introduction of portable, digitally integrated, and easy-to-use oxygen delivery devices, making life better for individuals living with respiratory conditions.

Today, patients are more empowered and informed than ever before. They actively seek treatment options that enable them to lead a better quality of life. The rising incidence of respiratory disorders has not only led to a demand for oxygen delivery devices but also driven the development of devices that empower patients to manage their conditions more independently.

As a response to the increasing prevalence of respiratory diseases, home healthcare has expanded rapidly. Patients prefer to receive care in the comfort of their homes, which has boosted the market for oxygen delivery devices designed for home use. These devices offer convenience, ease of use, and peace of mind to patients and their families.

The economic burden of respiratory disorders is substantial, affecting not only the healthcare system but also individuals and their families. As healthcare costs rise, patients and healthcare providers are searching for cost-effective, efficient solutions. Oxygen delivery devices have emerged as a critical component in managing the economic implications of respiratory disorders, providing a more affordable and accessible option for treatment.

Aging Global Population

The global demographic landscape is undergoing a profound transformation, characterized by a significant increase in the elderly population. This demographic shift, driven by longer life expectancy and declining birth rates, is creating unique challenges and opportunities across various sectors, particularly in healthcare.

Aging is often accompanied by a natural decline in lung function and an increased susceptibility to respiratory disorders. Conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, and sleep apnea become more prevalent as individuals grow older. This heightened vulnerability necessitates a greater reliance on respiratory support and oxygen therapy, driving the demand for respiratory oxygen delivery devices.

According to the United Nations, the world's population aged 60 and over is expected to double by 2050. This growing geriatric demographic represents a substantial market for healthcare-related products and services. As the elderly population expands, so does the demand for specialized medical devices, including respiratory oxygen delivery devices designed to cater to the unique needs of older individuals.

With advancing age often comes an increased prevalence of chronic diseases. These underlying health conditions frequently necessitate ongoing medical attention, including respiratory support. An aging population that requires continuous management of respiratory disorders spurs the development and sales of oxygen delivery devices, fostering market growth.

The preference for home healthcare among the elderly is a trend that aligns with the aging global population. Older individuals often seek to maintain their independence and receive care in the comfort of their homes. Oxygen delivery devices tailored for home use have become indispensable in this context, allowing seniors to manage their respiratory conditions effectively while staying at home.

As the aging population embraces technology, the market for user-friendly, digitally integrated oxygen delivery devices is expanding. These devices offer seniors greater convenience, mobility, and ease of use. Innovations such as portable oxygen concentrators enable the elderly to lead active lives while managing their respiratory conditions.

The economic impact of caring for an aging population with respiratory disorders is substantial. The burden on healthcare systems and families alike is a driving force behind the growth of the respiratory oxygen delivery devices market. Cost-effective and efficient oxygen delivery solutions have become a necessity in the face of increasing healthcare expenditures.

Rising Healthcare Expenditure

Healthcare expenditure is a critical indicator of a nation's commitment to the well-being of its citizens. Over the years, a notable upward trend in healthcare spending has emerged across the globe. This surge in investment, prompted by the increasing prevalence of respiratory disorders, has a significant impact on the growth of the global respiratory oxygen delivery devices market.

As healthcare budgets grow, so does the ability of healthcare systems to provide accessible and affordable respiratory care. This translates to an increased demand for respiratory oxygen delivery devices. A greater allocation of funds toward healthcare infrastructure ensures that advanced respiratory solutions are available to a broader population.

Increased healthcare spending supports research, development, and technological advancements in the healthcare sector. This includes the creation of more innovative and efficient respiratory oxygen delivery devices. These devices, with their enhanced features and ease of use, are gaining prominence, further accelerating market growth.

The surge in healthcare spending is closely linked to an improved quality of patient care. Healthcare facilities are better equipped, staffing levels are enhanced, and the patient experience is prioritized. Oxygen delivery devices play a significant role in maintaining patient comfort and health, making them an integral part of healthcare services.

With higher healthcare investments, there is a growing emphasis on preventive care. This includes raising awareness about respiratory health, early diagnosis, and education on respiratory disorders. An integral part of preventive care is the availability of efficient oxygen delivery devices, especially for individuals at risk or suffering from respiratory conditions.

As healthcare systems focus on cost-effective and patient-centered care, the home healthcare sector is expanding. Patients prefer to receive treatment in the comfort of their homes, which drives the demand for oxygen delivery devices designed for home use. The convenience, ease of use, and affordability of such devices are made possible by the increased healthcare expenditure.

Efficient oxygen delivery devices have a direct impact on patient outcomes. They help reduce the likelihood of complications and hospital readmissions, ultimately saving healthcare costs. This aligns with the objective of optimizing healthcare spending by investing in technologies that deliver better results and cost savings.

Awareness and Education

In the realm of healthcare, awareness and education serve as powerful tools for improving patient outcomes and driving innovation. The global respiratory oxygen delivery devices market is no exception. As awareness of respiratory disorders and their management continues to grow, and as educational initiatives expand, this sector sees a significant boost.

The cornerstone of effective respiratory care is an informed patient. Increased awareness about respiratory disorders, their symptoms, and available treatment options empowers individuals to seek appropriate care. Patients who are well-informed are more likely to use oxygen delivery devices correctly and consistently, resulting in improved health outcomes.

Education about the early signs of respiratory disorders encourages individuals to seek medical attention promptly. The earlier a respiratory condition is diagnosed, the better the chances of managing it effectively. This emphasis on early intervention drives the demand for oxygen delivery devices, which are often an integral part of treatment plans.

Education on the proper use of oxygen delivery devices ensures that patients can effectively manage their conditions. By understanding the importance of adherence to prescribed therapies, patients are more likely to utilize these devices as needed, leading to better management of respiratory disorders and a higher demand for these devices.

Awareness and education also extend to preventive measures. Individuals become more mindful of actions that can reduce the risk of respiratory disorders, such as avoiding smoking, maintaining a healthy lifestyle, and managing environmental triggers. This preventive approach ultimately reduces the incidence of respiratory conditions, but for those who do require treatment, it underscores the value of oxygen delivery devices.

Awareness and education don't just benefit patients but also healthcare providers and manufacturers. It fosters a supportive ecosystem where healthcare professionals are better equipped to diagnose and treat respiratory conditions, and manufacturers are driven to develop user-friendly and technologically advanced oxygen delivery devices.

As awareness grows, so does the demand for improved oxygen delivery devices. This drives research and development efforts aimed at creating more efficient, cost-effective, and patient-centric solutions. Manufacturers are constantly innovating to meet the evolving needs of the market.

Key Market Challenges

Pricing Pressures

In many healthcare systems, cost containment is a priority. The pressure to reduce healthcare expenses, including the cost of medical devices like respiratory oxygen delivery devices, can make it difficult for manufacturers to maintain profitability. Striking a balance between affordability and quality is a constant challenge.

Global Supply Chain Disruptions

The COVID-19 pandemic highlighted vulnerabilities in global supply chains. Disruptions in the supply of critical components and materials can disrupt manufacturing and distribution, affecting the availability of respiratory oxygen delivery devices when they are needed most.

Accessibility and Healthcare Disparities

Ensuring equitable access to respiratory oxygen delivery devices can be challenging, particularly in lower-resource regions. Healthcare disparities and differences in infrastructure can lead to unequal access to these life-saving devices, exacerbating health inequalities.

Key Market Trends

Portable and Wearable Devices

The demand for portable and wearable respiratory oxygen delivery devices is on the rise. Patients want the freedom to lead active lives while managing their conditions. Compact and user-friendly devices, such as wearable oxygen concentrators, are empowering individuals to go about their daily activities without cumbersome equipment, thereby improving their quality of life.

Smart and Connected Devices

The Internet of Things (IoT) is making its mark on the healthcare industry, and respiratory oxygen delivery devices are no exception. Smart, connected devices can collect and transmit data to healthcare professionals, providing real-time insights into patient health. These devices also enable remote monitoring and adjustments, ensuring that patients receive the most effective treatment.

Home Healthcare Expansion

The trend towards home healthcare is becoming increasingly prevalent. As healthcare systems seek to reduce hospital admissions and control costs, patients are benefiting from treatments and therapies at home. This expansion of home healthcare is driving the demand for home-friendly respiratory oxygen delivery devices, which are easy to use, maintain, and integrate into daily routines.

Segmental Insights

Product Insights

In 2023, the Oxygen Masks category was the market leader, boasting the highest revenue share. These masks offer a straightforward and efficient method for administering oxygen to patients in various clinical environments. Their user-friendly design makes them well-suited for both acute care situations and long-term oxygen therapy. Oxygen masks are especially valuable for patients needing low to moderate oxygen flow rates, with the flexibility to easily adjust to different oxygen concentrations. They are available in various sizes and styles to cater to diverse patient requirements, including both pediatric and adult populations. The familiarity of healthcare professionals with oxygen masks and their cost-effectiveness further bolster their dominance in the market, establishing them as an integral component of respiratory care protocols and driving market expansion.

Conversely, the Venturi Masks segment is anticipated to experience the most rapid growth during the forecast period. These masks offer precise and controlled oxygen delivery through a unique system that mixes oxygen with ambient air at specific ratios, ensuring accurate delivery of oxygen concentration. This capability is crucial in managing patients with respiratory conditions that require precise oxygen levels. Venturi masks are particularly favored for patients with chronic obstructive pulmonary disease (COPD), where maintaining precise oxygen saturation is of utmost importance.

Regional Insights

In 2023, Asia Pacific emerged as the dominant force in the market, securing the largest portion of revenue.The Asia Pacific region faces a substantial burden of respiratory illnesses like chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections. Factors like air pollution, high smoking rates, an aging population, and changing lifestyles contribute to this challenge. Consequently, there's a significant demand for respiratory oxygen delivery devices to manage these conditions, propelling market growth.Many nations in the Asia Pacific are undergoing rapid economic expansion and increasing healthcare expenditure. Governments are investing in healthcare infrastructure, such as hospitals and clinics, to enhance access to healthcare services. This investment extends to procuring respiratory oxygen delivery devices to address the rising demand for respiratory care, bolstering the region's market dominance.

The aging demographic in the Asia Pacific is fueling the prevalence of chronic respiratory diseases, heightening the necessity for respiratory oxygen delivery devices. With age, individuals become more vulnerable to conditions like COPD, necessitating oxygen therapy to alleviate symptoms and enhance quality of life. The expanding geriatric population significantly drives market growth in the region.The Asia Pacific boasts several leading manufacturers of respiratory oxygen delivery devices. These companies continually invest in research and development to introduce new products and enhance existing ones. Technological advancements, such as portable oxygen concentrators, advanced ventilators, and oxygen conserving devices, are gaining traction in the region, further solidifying market dominance.

Key Market Players

GE Healthcare Technologies Inc

Koninklijke Philips NV

ICU Medical Group Ltd (Smiths Medical Group Ltd)

Invacare Corp

Medtronic PLC

Fisher Paykel Healthcare Limited

ResMed Inc

CAIRE Inc

Linde Plc

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Report Scope:

In this report, the Global Respiratory Oxygen Delivery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Oxygen Delivery Devices Market,By Product:

• Oxygen Masks
• Nasal Cannula
• Venturi Masks
• Non-rebreather Masks
• Bag Valve Masks
• CPAP Masks
• Others

Respiratory Oxygen Delivery Devices Market,By End-use:

• Hospitals
• Outpatient Facilities
• Home Care
• Others

Respiratory Oxygen Delivery Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Oxygen Delivery Devices Market.

Available Customizations:

Global Respiratory Oxygen Delivery Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Respiratory Oxygen Delivery Devices Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others)
  • 5.2.2.By End-use (Hospitals, Outpatient Facilities, Home Care, Others)
  • 5.2.3.By Region
  • 5.2.4.By Company (2023)
• 5.3.Product Market Map
  • 5.3.1.By Product
  • 5.3.2.By End-use
  • 5.3.3.By Region

6.North America Respiratory Oxygen Delivery Devices Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others)
  • 6.2.2.By End-use (Hospitals, Outpatient Facilities, Home Care, Others)
  • 6.2.3.By Country
• 6.3.North America: Country Analysis
  • 6.3.1.United States Respiratory Oxygen Delivery Devices Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Product
      • 6.3.1.2.2.By End-use
  • 6.3.2.Canada Respiratory Oxygen Delivery Devices Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Product
      • 6.3.2.2.2.By End-use
  • 6.3.3.Mexico Respiratory Oxygen Delivery Devices Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Product
      • 6.3.3.2.2.By End-use

7.Europe Respiratory Oxygen Delivery Devices Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others)
  • 7.2.2.By End-use (Hospitals, Outpatient Facilities, Home Care, Others)
  • 7.2.3.By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.Germany Respiratory Oxygen Delivery Devices Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Product
      • 7.3.1.2.2.By End-use
  • 7.3.2.United Kingdom Respiratory Oxygen Delivery Devices Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Product
      • 7.3.2.2.2.By End-use
  • 7.3.3.France Respiratory Oxygen Delivery Devices Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Product
      • 7.3.3.2.2.By End-use
  • 7.3.4.Italy Respiratory Oxygen Delivery Devices Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Product
      • 7.3.4.2.2.By End-use
  • 7.3.5.Spain Respiratory Oxygen Delivery Devices Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Product
      • 7.3.5.2.2.By End-use

8.Asia-Pacific Respiratory Oxygen Delivery Devices Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others)
  • 8.2.2.By End-use (Hospitals, Outpatient Facilities, Home Care, Others)
  • 8.2.3.By Country
• 8.3.Asia-Pacific: Country Analysis
  • 8.3.1.China Respiratory Oxygen Delivery Devices Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Product
      • 8.3.1.2.2.By End-use
  • 8.3.2.Japan Respiratory Oxygen Delivery Devices Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Product
      • 8.3.2.2.2.By End-use
  • 8.3.3.India Respiratory Oxygen Delivery Devices Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Product
      • 8.3.3.2.2.By End-use
  • 8.3.4.Australia Respiratory Oxygen Delivery Devices Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Product
      • 8.3.4.2.2.By End-use
  • 8.3.5.South Korea Respiratory Oxygen Delivery Devices Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Product
      • 8.3.5.2.2.By End-use

9.South America Respiratory Oxygen Delivery Devices Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others)
  • 9.2.2.By End-use (Hospitals, Outpatient Facilities, Home Care, Others)
  • 9.2.3.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Respiratory Oxygen Delivery Devices Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Product
      • 9.3.1.2.2.By End-use
  • 9.3.2.Argentina Respiratory Oxygen Delivery Devices Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Product
      • 9.3.2.2.2.By End-use
  • 9.3.3.Colombia Respiratory Oxygen Delivery Devices Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Product
      • 9.3.3.2.2.By End-use

10.Middle East and Africa Respiratory Oxygen Delivery Devices Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1.By Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others)
  • 10.2.2.By End-use (Hospitals, Outpatient Facilities, Home Care, Others)
  • 10.2.3.By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Respiratory Oxygen Delivery Devices Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Product
      • 10.3.1.2.2.By End-use
  • 10.3.2.Saudi Arabia Respiratory Oxygen Delivery Devices Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Product
      • 10.3.2.2.2.By End-use
  • 10.3.3.UAE Respiratory Oxygen Delivery Devices Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Product
      • 10.3.3.2.2.By End-use
  • 10.3.4.Kuwait Respiratory Oxygen Delivery Devices Market Outlook
    • 10.3.4.1.Market Size Forecast
      • 10.3.4.1.1.By Value
    • 10.3.4.2.Market Share Forecast
      • 10.3.4.2.1.By Product
      • 10.3.4.2.2.By End-use

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Recent Development
• 12.2.Mergers Acquisitions
• 12.3.Product Launches

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Products

14.Competitive Landscape

• 14.1.GE Healthcare Technologies Inc
  • 14.1.1. Business Overview
  • 14.1.2.Product Offerings
  • 14.1.3.Recent Developments
  • 14.1.4.Financials (As Reported)
  • 14.1.5.Key Personnel
  • 14.1.6.SWOT Analysis
• 14.2.Koninklijke Philips NV
• 14.3.ICU Medical Group Ltd (Smiths Medical Group Ltd)
• 14.4.Invacare Corp
• 14.5.Medtronic PLC
• 14.6.Fisher Paykel Healthcare Limited
• 14.7.ResMed Inc
• 14.8.CAIRE Inc
• 14.9.Linde Plc
• 14.10.Shenzhen Mindray Bio-Medical Electronics Co., Ltd

15.Strategic Recommendations

16.About Us Disclaimer